Plotkin, [edited by] Stanley A.; Orenstein,, Walter A.; Offit, Paul A. (2013). Vaccines 6th ed. Edimburgo: Elsevier/Saunders. p. 208. ISBN9781455700905
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMID27733281. doi:10.1016/S0140-6736(16)31012-1
Pungpapong S, Kim WR, Poterucha JJ (2007). «Natural History of Hepatitis B Virus Infection: an Update for Clinicians». Mayo Clinic Proceedings. 82 (8): 967–975. PMID17673066. doi:10.4065/82.8.967 !CS1 manut: Usa parâmetro autores (link)
Williams R (2006). «Global challenges in liver disease». Hepatology (Baltimore, Md.). 44 (3): 521–526. PMID16941687. doi:10.1002/hep.21347 !CS1 manut: Usa parâmetro autores (link)
Global Burden of Disease Study 2013, Collaborators (22 de agosto de 2015). «Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet (London, England). 386 (9995): 743–800. PMID26063472. doi:10.1016/S0140-6736(15)60692-4
Terrault N, Roche B, Samuel D (julho de 2005). «Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective». Liver Transpl. 11 (7): 716–32. PMID15973718. doi:10.1002/lt.20492 !CS1 manut: Usa parâmetro autores (link)
El-Serag HB, Rudolph KL (junho de 2007). «Hepatocellular carcinoma: epidemiology and molecular carcinogenesis». Gastroenterology. 132 (7): 2557–76. PMID17570226. doi:10.1053/j.gastro.2007.04.061 !CS1 manut: Usa parâmetro autores (link)
El-Serag HB (22 de setembro de 2011). «Hepatocellular carcinoma». New England Journal of Medicine. 365 (12): 1118–27. PMID21992124. doi:10.1056/NEJMra1001683
Dienstag JL (fevereiro de 1981). «Hepatitis B as an immune complex disease». Seminars in Liver Disease. 1 (1): 45–57. PMID6126007. doi:10.1055/s-2008-1063929
Trepo C, Guillevin L (maio de 2001). «Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis». Journal of Autoimmunity. 16 (3): 269–74. PMID11334492. doi:10.1006/jaut.2000.0502
Alpert E, Isselbacher KJ, Schur PH (julho de 1971). «The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies». The New England Journal of Medicine. 285 (4): 185–9. PMID4996611. doi:10.1056/NEJM197107222850401
Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL (dezembro de 1970). «Association between polyarteritis and Australia antigen». Lancet. 2 (7684): 1149–53. PMID4098431. doi:10.1016/S0140-6736(70)90339-9
Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM (maio de 1991). «Membranous nephropathy related to hepatitis B virus in adults». The New England Journal of Medicine. 324 (21): 1457–63. PMID2023605. doi:10.1056/NEJM199105233242103
Takekoshi Y, Tanaka M, Shida N, Satake Y, Saheki Y, Matsumoto S (novembro de 1978). «Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children». Lancet. 2 (8099): 1065–8. PMID82085. doi:10.1016/S0140-6736(78)91801-9
Lai CL, Yuen MF (julho de 2007). «The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points». Annals of Internal Medicine. 147 (1): 58–61. PMID17606962. doi:10.7326/0003-4819-147-1-200707030-00010
Alberti A, Caporaso N (janeiro de 2011). «HBV therapy: guidelines and open issues». Digestive and Liver Disease. 43 (Suppl 1): S57–63. PMID21195373. doi:10.1016/S1590-8658(10)60693-7
Dienstag JL (2008). «Hepatitis B Virus Infection». New England Journal of Medicine. 359 (14): 1486–1500. PMID18832247. doi:10.1056/NEJMra0801644
Pramoolsinsup C (fevereiro de 2002). «Management of viral hepatitis B». Journal of Gastroenterology and Hepatology. 17 (Suppl): S125–45. PMID12000599. doi:10.1046/j.1440-1746.17.s1.3.x
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMID27733281. doi:10.1016/S0140-6736(16)31012-1
Pungpapong S, Kim WR, Poterucha JJ (2007). «Natural History of Hepatitis B Virus Infection: an Update for Clinicians». Mayo Clinic Proceedings. 82 (8): 967–975. PMID17673066. doi:10.4065/82.8.967 !CS1 manut: Usa parâmetro autores (link)
Williams R (2006). «Global challenges in liver disease». Hepatology (Baltimore, Md.). 44 (3): 521–526. PMID16941687. doi:10.1002/hep.21347 !CS1 manut: Usa parâmetro autores (link)
Global Burden of Disease Study 2013, Collaborators (22 de agosto de 2015). «Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet (London, England). 386 (9995): 743–800. PMID26063472. doi:10.1016/S0140-6736(15)60692-4
Terrault N, Roche B, Samuel D (julho de 2005). «Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective». Liver Transpl. 11 (7): 716–32. PMID15973718. doi:10.1002/lt.20492 !CS1 manut: Usa parâmetro autores (link)
El-Serag HB, Rudolph KL (junho de 2007). «Hepatocellular carcinoma: epidemiology and molecular carcinogenesis». Gastroenterology. 132 (7): 2557–76. PMID17570226. doi:10.1053/j.gastro.2007.04.061 !CS1 manut: Usa parâmetro autores (link)
El-Serag HB (22 de setembro de 2011). «Hepatocellular carcinoma». New England Journal of Medicine. 365 (12): 1118–27. PMID21992124. doi:10.1056/NEJMra1001683
Gan SI, Devlin SM, Scott-Douglas NW, Burak KW (outubro de 2005). «Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis B infection». Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 19 (10): 625–9. PMID16247526
Dienstag JL (fevereiro de 1981). «Hepatitis B as an immune complex disease». Seminars in Liver Disease. 1 (1): 45–57. PMID6126007. doi:10.1055/s-2008-1063929
Trepo C, Guillevin L (maio de 2001). «Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis». Journal of Autoimmunity. 16 (3): 269–74. PMID11334492. doi:10.1006/jaut.2000.0502
Alpert E, Isselbacher KJ, Schur PH (julho de 1971). «The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies». The New England Journal of Medicine. 285 (4): 185–9. PMID4996611. doi:10.1056/NEJM197107222850401
Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL (dezembro de 1970). «Association between polyarteritis and Australia antigen». Lancet. 2 (7684): 1149–53. PMID4098431. doi:10.1016/S0140-6736(70)90339-9
Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, Lai FM (maio de 1991). «Membranous nephropathy related to hepatitis B virus in adults». The New England Journal of Medicine. 324 (21): 1457–63. PMID2023605. doi:10.1056/NEJM199105233242103
Takekoshi Y, Tanaka M, Shida N, Satake Y, Saheki Y, Matsumoto S (novembro de 1978). «Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children». Lancet. 2 (8099): 1065–8. PMID82085. doi:10.1016/S0140-6736(78)91801-9
Lai CL, Yuen MF (julho de 2007). «The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points». Annals of Internal Medicine. 147 (1): 58–61. PMID17606962. doi:10.7326/0003-4819-147-1-200707030-00010
Alberti A, Caporaso N (janeiro de 2011). «HBV therapy: guidelines and open issues». Digestive and Liver Disease. 43 (Suppl 1): S57–63. PMID21195373. doi:10.1016/S1590-8658(10)60693-7
Dienstag JL (2008). «Hepatitis B Virus Infection». New England Journal of Medicine. 359 (14): 1486–1500. PMID18832247. doi:10.1056/NEJMra0801644
Pramoolsinsup C (fevereiro de 2002). «Management of viral hepatitis B». Journal of Gastroenterology and Hepatology. 17 (Suppl): S125–45. PMID12000599. doi:10.1046/j.1440-1746.17.s1.3.x